Saltar al contenido
Merck

[Effect of mefenamic acid and sodium salicylate on lymphocyte transformation due to phytohemagglutinin].

Farmakologiia i toksikologiia (1980-03-01)
I V Petrova, G M Aleksandrova
RESUMEN

It is established in in-vitro experiments that mefenamic acid and sodium salicylate inhibit to an equal measure the cell immunity test, a reaction of blast transformation of lymphocytes. The effect increases with the higher concentration of the drugs under study and depends on the time they are introduced into the culture with respect to the introduction of the non-specific mitotic stimulant phytohemagglutinin.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Salicilato de sodio, ReagentPlus®, ≥99.5% (titration)
Sigma-Aldrich
Salicilato de sodio, 98.0-102.0% anhydrous basis, meets USP testing specifications
Sigma-Aldrich
Mefenamic acid
Sigma-Aldrich
Salicilato de sodio, ≥99.5% (HPLC), puriss. p.a.
Sigma-Aldrich
Salicilato de sodio, puriss. p.a., reag. Ph. Eur., 99.5-101.0% (calc. to the dried substance)
Supelco
Mefenamic acid, analytical standard
Mefenamic acid, European Pharmacopoeia (EP) Reference Standard
Salicilato de sodio, European Pharmacopoeia (EP) Reference Standard